Please login to the form below

Not currently logged in
Email:
Password:

CicloMulsion

This page shows the latest CicloMulsion news and features for those working in and with pharma, biotech and healthcare.

Sanofi licenses cardiovascular therapy in South Korea

Sanofi licenses cardiovascular therapy in South Korea

The deal - signed by Sanofi's Asian subsidiary and covering only the South Korean market - covers a new formulation of cyclophilin inhibitor cyclosporine A - called CicloMulsion - that is in phase III ... NeuroVive's chief executive Mikael Brönnegård

Latest news

  • inVentiv extends collaboration with NeuroVive inVentiv extends collaboration with NeuroVive

    The new deal will see consultancy firm InVentiv assist NeuroVive with the global commercialisation of its lead product, CicloMulsion, which is currently in phase III trials to determine its effectiveness in ... NeuroVive and inVentiv are already

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Latest Intelligence

  • Pharma deals during November 2012 Pharma deals during November 2012

    8. Sihuan Pharmaceutical / NeuroVive Pharmaceutical. Collaboration agreement. CicloMulsion / NeuroSTAT to treat heart reperfusion / traumatic brain injuries. ... Canadian research facility.  South Korea market.  Pursuant to the collaboration agreement,

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
JPA Health Communications

JPA Health is an award-winning public relations, marketing and advocacy firm known for sharing our clients’ commitment to making people...

Latest intelligence

The Exhibition Hall: Past, Present and Future
As I sit here at another pharma conference, I start to reflect on how they have changed over the years....
Success breeds success
This week we received the exciting news that we have been shortlisted for the Times Business Awards 2019, Tunbridge Wells in the 'Best Business 1-25 Employees' category....
Turning learning into action: The challenge of behaviour change
...

Infographics